Clarivate Analytics plc (NYSE:CCC; CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today expanded its industry-leading life science intelligence offerings with the launch of Cortellis Digital Health Intelligence™. This new, first-of-its-kind solution will help drug, device and technology developers navigate the dynamic digital health landscape with intelligence focused on virtual, consumer-centric solutions (including both hardware and software) that enable health management or patient care in real-life settings.
